KA
Kelly Anne Reinke
About Kelly Anne Reinke
Data last updated:
Kelly Anne Reinke is a Director at Molecular Products Group India Private Limited (since 2023). The company operates in Travel and Hospitality. Molecular Products Group India Private Limited reported revenue of ₹86.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Molecular Products Group India Private Limited U74120MH2016FTC271967 | Director | 26 May 2023 | 2016 | ₹86.3 Lakh (FY 2025) | Active |
Board colleagues of Kelly Anne Reinke
| Name | DIN | Company | Designation |
|---|---|---|---|
| Brandon Christopher Smith | 10177291 | Molecular Products Group India Private Limited | Director |
| Jan Willem Radstaak | 07288946 | Molecular Products Group India Private Limited | Director |
| Vikrant Bapusaheb Patil | 01125572 | Molecular Products Group India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kelly Anne Reinke
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kelly Anne Reinke
Kelly Anne Reinke currently holds 1 directorship: Molecular Products Group India Private Limited (Director, since 26 May 2023, revenue ₹86.3 Lakh (FY 2025)).
Kelly Anne Reinke was first appointed on 26 May 2023 as Director at Molecular Products Group India Private Limited.
The current boards of Kelly Anne Reinke's companies include Brandon Christopher Smith (Molecular Products Group India Private Limited), Jan Willem Radstaak (Molecular Products Group India Private Limited), Vikrant Bapusaheb Patil (Molecular Products Group India Private Limited).